Gastrointestinal Therapeutics and Diagnostics Market - Global Outlook and Forecast 2021-2027

Code: RW00014647277
Market Monitor Global
Dec-2021
Life Sciences
92 Pages

This report contains market size and forecasts of Gastrointestinal Therapeutics and Diagnostics in Global, including the following market information:
Global Gastrointestinal Therapeutics and Diagnostics Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global top five companies in 2020 (%)
The global Gastrointestinal Therapeutics and Diagnostics market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
Publisher has surveyed the Gastrointestinal Therapeutics and Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gastrointestinal Therapeutics and Diagnostics Market, By Type, 2016-2021, 2022-2027 ($ millions)
Global Gastrointestinal Therapeutics and Diagnostics Market Segment Percentages, By Type, 2020 (%)
Diagnostics
Therapeutics

China Gastrointestinal Therapeutics and Diagnostics Market, By Application, 2016-2021, 2022-2027 ($ millions)
China Gastrointestinal Therapeutics and Diagnostics Market Segment Percentages, By Application, 2020 (%)
Gastroenteritis
GI Bleeding
Irritable Bowel Syndrome
Peptic Ulcer Disease (PUD)
Others

Global Gastrointestinal Therapeutics and Diagnostics Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)
Global Gastrointestinal Therapeutics and Diagnostics Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Gastrointestinal Therapeutics and Diagnostics Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)
Total Gastrointestinal Therapeutics and Diagnostics Market Competitors Revenues Share in Global, by Players 2020 (%)
Further, the report presents profiles of competitors in the market, including the following:
Abbott Laboratories
AstraZeneca
Eisai
Johnson & Johnson
Salix Pharmaceuticals
Takeda Pharmaceutical Company

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Gastrointestinal Therapeutics and Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gastrointestinal Therapeutics and Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gastrointestinal Therapeutics and Diagnostics Overall Market Size
2.1 Global Gastrointestinal Therapeutics and Diagnostics Market Size: 2021 VS 2027
2.2 Global Gastrointestinal Therapeutics and Diagnostics Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gastrointestinal Therapeutics and Diagnostics Players in Global Market
3.2 Top Global Gastrointestinal Therapeutics and Diagnostics Companies Ranked by Revenue
3.3 Global Gastrointestinal Therapeutics and Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Gastrointestinal Therapeutics and Diagnostics Companies in Global Market, by Revenue in 2020
3.5 Global Companies Gastrointestinal Therapeutics and Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gastrointestinal Therapeutics and Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Gastrointestinal Therapeutics and Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Gastrointestinal Therapeutics and Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gastrointestinal Therapeutics and Diagnostics Market Size Markets, 2021 & 2027
4.1.2 Diagnostics
4.1.3 Therapeutics
4.2 By Type - Global Gastrointestinal Therapeutics and Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Gastrointestinal Therapeutics and Diagnostics Revenue, 2016-2021
4.2.2 By Type - Global Gastrointestinal Therapeutics and Diagnostics Revenue, 2022-2027
4.2.3 By Type - Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share, 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gastrointestinal Therapeutics and Diagnostics Market Size, 2021 & 2027
5.1.2 Gastroenteritis
5.1.3 GI Bleeding
5.1.4 Irritable Bowel Syndrome
5.1.5 Peptic Ulcer Disease (PUD)
5.1.6 Others
5.2 By Application - Global Gastrointestinal Therapeutics and Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Gastrointestinal Therapeutics and Diagnostics Revenue, 2016-2021
5.2.2 By Application - Global Gastrointestinal Therapeutics and Diagnostics Revenue, 2022-2027
5.2.3 By Application - Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share, 2016-2027
6 Sights by Region
6.1 By Region - Global Gastrointestinal Therapeutics and Diagnostics Market Size, 2021 & 2027
6.2 By Region - Global Gastrointestinal Therapeutics and Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Gastrointestinal Therapeutics and Diagnostics Revenue, 2016-2021
6.2.2 By Region - Global Gastrointestinal Therapeutics and Diagnostics Revenue, 2022-2027
6.2.3 By Region - Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share, 2016-2027
6.3 North America
6.3.1 By Country - North America Gastrointestinal Therapeutics and Diagnostics Revenue, 2016-2027
6.3.2 US Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.3.3 Canada Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.3.4 Mexico Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.4 Europe
6.4.1 By Country - Europe Gastrointestinal Therapeutics and Diagnostics Revenue, 2016-2027
6.4.2 Germany Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.4.3 France Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.4.4 U.K. Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.4.5 Italy Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.4.6 Russia Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.4.7 Nordic Countries Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.4.8 Benelux Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.5 Asia
6.5.1 By Region - Asia Gastrointestinal Therapeutics and Diagnostics Revenue, 2016-2027
6.5.2 China Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.5.3 Japan Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.5.4 South Korea Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.5.5 Southeast Asia Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.5.6 India Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.6 South America
6.6.1 By Country - South America Gastrointestinal Therapeutics and Diagnostics Revenue, 2016-2027
6.6.2 Brazil Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.6.3 Argentina Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue, 2016-2027
6.7.2 Turkey Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.7.3 Israel Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.7.4 Saudi Arabia Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
6.7.5 UAE Gastrointestinal Therapeutics and Diagnostics Market Size, 2016-2027
7 Players Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Corporate Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Major Product Offerings
7.1.4 Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue in Global (2016-2021)
7.1.5 Abbott Laboratories Key News
7.2 AstraZeneca
7.2.1 AstraZeneca Corporate Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Major Product Offerings
7.2.4 AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue in Global (2016-2021)
7.2.5 AstraZeneca Key News
7.3 Eisai
7.3.1 Eisai Corporate Summary
7.3.2 Eisai Business Overview
7.3.3 Eisai Gastrointestinal Therapeutics and Diagnostics Major Product Offerings
7.3.4 Eisai Gastrointestinal Therapeutics and Diagnostics Revenue in Global (2016-2021)
7.3.5 Eisai Key News
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Corporate Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Major Product Offerings
7.4.4 Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue in Global (2016-2021)
7.4.5 Johnson & Johnson Key News
7.5 Salix Pharmaceuticals
7.5.1 Salix Pharmaceuticals Corporate Summary
7.5.2 Salix Pharmaceuticals Business Overview
7.5.3 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Major Product Offerings
7.5.4 Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue in Global (2016-2021)
7.5.5 Salix Pharmaceuticals Key News
7.6 Takeda Pharmaceutical Company
7.6.1 Takeda Pharmaceutical Company Corporate Summary
7.6.2 Takeda Pharmaceutical Company Business Overview
7.6.3 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Major Product Offerings
7.6.4 Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue in Global (2016-2021)
7.6.5 Takeda Pharmaceutical Company Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Gastrointestinal Therapeutics and Diagnostics Market Opportunities & Trends in Global Market
Table 2. Gastrointestinal Therapeutics and Diagnostics Market Drivers in Global Market
Table 3. Gastrointestinal Therapeutics and Diagnostics Market Restraints in Global Market
Table 4. Key Players of Gastrointestinal Therapeutics and Diagnostics in Global Market
Table 5. Top Gastrointestinal Therapeutics and Diagnostics Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Gastrointestinal Therapeutics and Diagnostics Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Gastrointestinal Therapeutics and Diagnostics Revenue Share by Companies, 2016-2021
Table 8. Global Companies Gastrointestinal Therapeutics and Diagnostics Product Type
Table 9. List of Global Tier 1 Gastrointestinal Therapeutics and Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gastrointestinal Therapeutics and Diagnostics Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type - Global Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Gastrointestinal Therapeutics and Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Gastrointestinal Therapeutics and Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application - Global Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Gastrointestinal Therapeutics and Diagnostics Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Gastrointestinal Therapeutics and Diagnostics Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region - Global Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Gastrointestinal Therapeutics and Diagnostics Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Gastrointestinal Therapeutics and Diagnostics Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2022-2027
Table 30. Abbott Laboratories Corporate Summary
Table 31. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Product Offerings
Table 32. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue (US$, Mn), (2016-2021)
Table 33. AstraZeneca Corporate Summary
Table 34. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Product Offerings
Table 35. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue (US$, Mn), (2016-2021)
Table 36. Eisai Corporate Summary
Table 37. Eisai Gastrointestinal Therapeutics and Diagnostics Product Offerings
Table 38. Eisai Gastrointestinal Therapeutics and Diagnostics Revenue (US$, Mn), (2016-2021)
Table 39. Johnson & Johnson Corporate Summary
Table 40. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Product Offerings
Table 41. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue (US$, Mn), (2016-2021)
Table 42. Salix Pharmaceuticals Corporate Summary
Table 43. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Product Offerings
Table 44. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue (US$, Mn), (2016-2021)
Table 45. Takeda Pharmaceutical Company Corporate Summary
Table 46. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Product Offerings
Table 47. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue (US$, Mn), (2016-2021)
List of Figures
Figure 1. Gastrointestinal Therapeutics and Diagnostics Segment by Type
Figure 2. Gastrointestinal Therapeutics and Diagnostics Segment by Application
Figure 3. Global Gastrointestinal Therapeutics and Diagnostics Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Gastrointestinal Therapeutics and Diagnostics Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Gastrointestinal Therapeutics and Diagnostics Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gastrointestinal Therapeutics and Diagnostics Revenue in 2020
Figure 8. By Type - Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share, 2016-2027
Figure 9. By Application - Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share, 2016-2027
Figure 10. By Region - Global Gastrointestinal Therapeutics and Diagnostics Revenue Market Share, 2016-2027
Figure 11. By Country - North America Gastrointestinal Therapeutics and Diagnostics Revenue Market Share, 2016-2027
Figure 12. US Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Gastrointestinal Therapeutics and Diagnostics Revenue Market Share, 2016-2027
Figure 16. Germany Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 17. France Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Gastrointestinal Therapeutics and Diagnostics Revenue Market Share, 2016-2027
Figure 24. China Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 28. India Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Gastrointestinal Therapeutics and Diagnostics Revenue Market Share, 2016-2027
Figure 30. Brazil Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Gastrointestinal Therapeutics and Diagnostics Revenue Market Share, 2016-2027
Figure 33. Turkey Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Gastrointestinal Therapeutics and Diagnostics Revenue, (US$, Mn), 2016-2027
Figure 37. Abbott Laboratories Gastrointestinal Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. AstraZeneca Gastrointestinal Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Eisai Gastrointestinal Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Johnson & Johnson Gastrointestinal Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Salix Pharmaceuticals Gastrointestinal Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Takeda Pharmaceutical Company Gastrointestinal Therapeutics and Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Abbott Laboratories
AstraZeneca
Eisai
Johnson & Johnson
Salix Pharmaceuticals
Takeda Pharmaceutical Company

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE